Date Filed | Type | Description |
08/14/2023 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
05/24/2023 |
4
| MPM ASSET MANAGEMENT LLC (10% Owner) has filed a Form 4 on TCR2 THERAPEUTICS INC.
Txns:
| Sold 70,170 shares
@ $1.88, valued at
$131.9k
Exercised (in-or-at-the-money) 42,761 warrants
@ $0.74, valued at
$31.6k
Exercised (in-or-at-the-money) 135,508 warrants
@ $0.74, valued at
$100.3k
|
|
05/12/2023 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
02/14/2023 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
11/14/2022 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
08/11/2022 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
05/13/2022 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
02/11/2022 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
08/13/2021 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
05/13/2021 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
04/15/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
04/13/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
02/16/2021 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
02/12/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
02/09/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
02/04/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
01/27/2021 |
4
| MPM BioVentures 2014, L.P. (10% Owner) has filed a Form 4 on Harpoon Therapeutics, Inc.
Txns:
| Sold 13,006 shares
@ $21.23, valued at
$276.1k
Sold 1,363 shares
@ $21.08, valued at
$28.7k
Sold 706,825 shares
@ $20, valued at
$14.1M
|
|
01/22/2021 |
4
| MPM BioVentures 2014, L.P. (10% Owner) has filed a Form 4 on Harpoon Therapeutics, Inc.
Txns:
| Sold 15,694 shares
@ $23.95, valued at
$375.9k
Sold 2,000 shares
@ $24.71, valued at
$49.4k
Disposed of 101,646 shares
@ $0 Sold 20,979 shares
@ $22.11, valued at
$463.8k
Sold 4,887 shares
@ $22.61, valued at
$110.5k
Sold 200 shares
@ $23.77, valued at
$4.8k
Sold 24,695 shares
@ $21.72, valued at
$536.4k
|
|
11/13/2020 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
10/08/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
10/01/2020 |
3
| MPM BioVentures 2014, L.P. (10% Owner) has filed a Form 3 on Oncorus, Inc. |
08/12/2020 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
05/13/2020 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
02/14/2020 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
11/14/2019 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
08/14/2019 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
05/29/2019 |
13F-HR/A
| Form 13F-HR/A - Quarterly report filed by institutional managers, Holdings: [Amend] |
05/13/2019 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
02/21/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
02/14/2019 |
4
| MPM BioVentures 2014, L.P. (10% Owner) has filed a Form 4 on Harpoon Therapeutics, Inc.
Txns:
| Converted 1,525,164 shares
@ $0 Converted 1,578,751 shares
@ $0 Converted 417,852 shares
@ $0 Sold 1,524 shares
@ $14, valued at
$21.3k
Bought 250,000 shares
@ $14, valued at
$3.5M
Converted 1,525,164 preferred shares
@ $0 Converted 1,578,751 preferred shares
@ $0 Converted 417,852 preferred shares
@ $0 Exercised (in-or-at-the-money) 25,418 warrants
@ $0.0492, valued at
$1.3k
Exercised (in-or-at-the-money) 57,192 warrants
@ $0.0492, valued at
$2.8k
Exercised (in-or-at-the-money) 171,579 warrants
@ $0.0492, valued at
$8.4k
|
|
02/13/2019 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
02/13/2019 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
02/07/2019 |
3
| MPM BioVentures 2014, L.P. (10% Owner) has filed a Form 3 on Harpoon Therapeutics, Inc. |
11/14/2018 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
|